ForSight VISION5, Inc.
191 Jefferson Drive
ForSight VISION5 was founded in 2010 as the fifth company created by the ophthalmic product incubator, ForSight Labs. ForSight VISION5 is developing non-invasive products that replace eye drops and provide sustained therapy for major eye diseases including glaucoma, dry eye, and allergy. The company is currently completing its Phase 2 activities for its lead product, the Bimatoprost Ring.
Founder: Eugene de Juan, Jr., MD
CEO: Angela MacFarlane
CTO: Cary Reich, PhD
Please click here for clinical trial information.